✦ LIBER ✦

203 Intensive CODE regimen for the treatment of limited and extensive stage small cell lung carcinoma

✍ Scribed by Franciosi, V.; Vasini, G.; Leonardi, F.; Ceci, G.; Mambrini, A.; Quarta, M.C.; Cocconi, G.

Book ID: 122495999
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 149 KB
Volume: 18
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(97)89584-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose-intensive therapy for extensive-sta

Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: Long-term outcome

✍ Anthony D Elias; Arthur T Skarin; Paul Richardson; Joseph Ibrahim; Mary McCauley 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Radiation therapy for limited stage smal

Radiation therapy for limited stage small cell carcinoma of the lung

✍ James O. Gates; Rao V.P. Mantravadi; John N. Crawford; Deepchand Bajpai; John D. 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 251 KB

Small cell carcinoma of the lung: Result

Small cell carcinoma of the lung: Results of combined modality treatment of limited stage patients

✍ David J. Harter; David L. Howe; James E. Bruckman; John R. Feagler 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Calculation of received dose intensity f

Calculation of received dose intensity for combinations of drugs using small-cell lung carcinoma treatment regimens as examples

✍ Galen L. Wampler; John G. Fryer 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 872 KB

Calculation of received dose intensity f

Calculation of received dose intensity for combinations of drugs using small-cell lung carcinoma treatment regimens as examples

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Results of combined-modality therapy for

Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly

✍ Steven E. Schild; Philip J. Stella; Burke J. Brooks; Sumithra Mandrekar; James A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twice‐daily radiotherapy (BIDRT) or once‐daily radiotherapy (QDRT) resulted in a better outcome for patients with limited‐st